SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-21-000012
Filing Date
2021-05-07
Accepted
2021-05-07 08:29:41
Documents
78
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20210331x10q.htm   iXBRL 10-Q 1809957
2 EX-31.1 anip-20210331ex31140cbc0.htm EX-31.1 11356
3 EX-31.2 anip-20210331ex31234ad67.htm EX-31.2 10776
4 EX-32.1 anip-20210331ex3217f87ea.htm EX-32.1 8602
  Complete submission text file 0001023024-21-000012.txt   7659854

Data Files

Seq Description Document Type Size
5 EX-101.SCH anip-20210331.xsd EX-101.SCH 48122
6 EX-101.CAL anip-20210331_cal.xml EX-101.CAL 63570
7 EX-101.DEF anip-20210331_def.xml EX-101.DEF 206396
8 EX-101.LAB anip-20210331_lab.xml EX-101.LAB 385679
9 EX-101.PRE anip-20210331_pre.xml EX-101.PRE 385374
10 EXTRACTED XBRL INSTANCE DOCUMENT anip-20210331x10q_htm.xml XML 1447643
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 21900376
SIC: 2834 Pharmaceutical Preparations